Shinichi Imafuku Selected Research

Shinichi Imafuku Research Topics

Disease

34	Psoriasis (Pustulosis Palmaris et Plantaris) 07/2022 - 03/2006
5	Psoriatic Arthritis 02/2022 - 08/2016
4	Infections 02/2022 - 01/2013
4	Herpes Zoster 01/2021 - 06/2017
4	Neoplasms (Cancer) 06/2017 - 11/2007
3	Atopic Dermatitis (Atopic Eczema) 01/2019 - 09/2015
2	Hypersensitivity (Allergy) 04/2022 - 11/2020
2	Hidradenitis Suppurativa 01/2021 - 09/2019
2	Miliary Tuberculosis 02/2020 - 06/2013
2	Diarrhea 01/2019 - 08/2017
2	Nasopharyngitis 01/2019 - 08/2017
2	Nausea 01/2019 - 06/2017
2	Bowen's Disease (Disease, Bowen) 07/2016 - 11/2007
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 07/2016 - 11/2007
2	Skin Diseases (Skin Disease) 07/2014 - 11/2007
2	Neurofibroma 10/2013 - 09/2013
2	Neurofibromatosis 1 (Neurofibromatosis Type I) 10/2013 - 09/2013
2	Dermatomyositis (Dermatopolymyositis) 07/2013 - 01/2004
2	Lymphoma (Lymphomas) 08/2012 - 03/2012
1	Herpes Labialis (Fever Blister) 02/2022
1	Diabetic Foot 01/2022
1	Wounds and Injuries (Trauma) 01/2022
1	Ulcer 01/2022
1	T-Cell Leukemia (Leukemia, T Cell) 11/2021
1	Necrosis 06/2021
1	Rheumatoid Arthritis 05/2021
1	Hematologic Neoplasms (Hematological Malignancy) 01/2021
1	Inflammation (Inflammations) 04/2020
1	Tuberculosis (Tuberculoses) 02/2020
1	Latent Tuberculosis 02/2020
1	Urticaria (Hives) 02/2020
1	Hypohidrosis 02/2020
1	Abscess 09/2019
1	Pain (Aches) 09/2019
1	Headache (Headaches) 01/2019
1	Kaposi Varicelliform Eruption (Eczema Herpeticum) 12/2018
1	Exfoliative Dermatitis (Erythroderma) 06/2018
1	Hyperuricemia 12/2017
1	Gouty Arthritis 12/2017

Drug/Important Bio-Agent (IBA)

7	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2021 - 12/2012
6	apremilastIBA 07/2022 - 08/2017
5	Adalimumab (Humira)FDA Link 01/2021 - 02/2018
4	Biological ProductsIBA 03/2022 - 02/2018
4	Proteins (Proteins, Gene)FDA Link 07/2014 - 03/2006
3	Prostaglandins AIBA 06/2021 - 08/2016
3	Immunoglobulins (Immunoglobulin)IBA 06/2021 - 07/2013
3	Janus Kinase InhibitorsIBA 05/2021 - 08/2016
3	Infliximab (Remicade)FDA Link 03/2020 - 06/2015
3	AntibodiesIBA 03/2020 - 07/2013
3	Pharmaceutical PreparationsIBA 05/2019 - 04/2015
3	secukinumabIBA 02/2018 - 09/2016
3	Immunoglobulin G (IgG)IBA 02/2018 - 07/2013
3	Cyclosporine (Ciclosporin)FDA LinkGeneric 10/2017 - 01/2004
2	Certolizumab Pegol FDA Link 01/2022 - 06/2021
2	Phosphodiesterase 4 InhibitorsIBA 11/2021 - 08/2017
2	calcipotriene (calcipotriol)FDA LinkGeneric 07/2021 - 04/2016
2	tildrakizumabIBA 06/2021 - 06/2021
2	Monoclonal AntibodiesIBA 06/2021 - 09/2016
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2019
2	CytokinesIBA 01/2021 - 10/2013
2	Interleukin-17 (Interleukin 17)IBA 04/2020 - 07/2017
2	InterleukinsIBA 04/2020 - 03/2020
2	Interleukin-12 (IL 12)IBA 03/2020 - 02/2020
2	Ustekinumab (CNTO 1275)FDA Link 03/2020 - 12/2012
2	InterferonsIBA 02/2020 - 06/2013
2	Complement System Proteins (Complement)IBA 02/2018 - 06/2017
2	EnzymesIBA 06/2017 - 06/2013
2	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2016 - 01/2004
2	Cholecalciferol (Vitamin D3)FDA Link 09/2013 - 03/2012
1	deucravacitinibIBA 07/2022
1	TYK2 Kinase (Tyrosine Kinase 2)IBA 07/2022
1	MetalsIBA 04/2022
1	brodalumabIBA 03/2022
1	DNA (Deoxyribonucleic Acid)IBA 02/2022
1	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 02/2022
1	Therapeutic UsesIBA 01/2022
1	Vascular Endothelial Growth FactorsIBA 01/2022
1	Surface Antigens (Surface Antigen)IBA 11/2021
1	betamethasone-17,21-dipropionate (betamethasone dipropionate)FDA LinkGeneric 07/2021
1	Biological FactorsIBA 06/2021
1	baricitinibIBA 05/2021
1	Glycoproteins (Glycoprotein)IBA 01/2021
1	Subunit VaccinesIBA 01/2021
1	Heparin (Liquaemin)FDA LinkGeneric 11/2020
1	Isoniazid (Ftivazide)FDA LinkGeneric 02/2020
1	Omalizumab (Xolair)FDA Link 02/2020
1	Tumor Necrosis Factor InhibitorsIBA 02/2020
1	Cholinergic Agents (Cholinergics)IBA 02/2020
1	Indicators and Reagents (Reagents)IBA 12/2019
1	Immunoglobulin E (IgE)IBA 06/2018
1	Uric Acid (Urate)IBA 12/2017
1	ixekizumabIBA 11/2017
1	DNA Primase (Primase)IBA 11/2017
1	Valacyclovir (Valtrex)FDA LinkGeneric 11/2017

Therapy/Procedure

10	Therapeutics 02/2022 - 06/2013
3	Biological Therapy 02/2022 - 02/2017
1	Transplantation 01/2022
1	Heterologous Transplantation (Xenotransplantation) 01/2022
1	Immunotherapy 04/2020
1	Cardiopulmonary Resuscitation (CPR) 02/2018